from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0516c/-

LFCtreatmentdescriptionclass of inhibitor

1.785

Amikacinug/mL Amikacintranslation

1.096

Cap5-10ug/mL Capreomycintranslation

0.999

Rox10-50 ug/mL Roxithromycintranslation

0.646

SM2-5 ug/mL Streptomycintranslation

1.269

Tet5-10 ug/mL Tetracyclinetranslation

-0.434

Rif0.2-5ug/mL Rifampicintranscription

-0.231

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.826

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.511

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.620

CPZ10-50 ug/mL Chlorpromazinerespiration

0.860

Clofazimine10-13 ug/mL Clofaziminerespiration

0.311

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.480

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.782

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.739

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.517

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.333

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.822

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.338

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.535

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.295

KCN5-20 ug/mL Potassium cyaniderespiration

0.340

NaN30.2-2 mM Sodium aziderespiration

-0.102

Nigericin50 uM Nigericinrespiration

0.304

TRC10-150 ug/mL Triclosanrespiration

0.529

TRZ10-25 ug/mL Thioridazinerespiration

-0.197

Valinomycin0.5-10 uM Valinomycinrespiration

0.173

ZnSO42 mM ZnSO4respiration

-0.588

menadione6-10 ug/mL Menadionerespiration

0.827

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.254

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.272

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.379

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.551

NRP_1Non-replicating persistence stage 1dosRassociated

-0.033

Amp0.2mg/mL AmpicillincellWall

0.295

Cephalexin20-100 ug/mL CephalexincellWall

-1.600

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.302

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.346

EMB10-20 ug/mL EthambutolcellWall

-2.164

Eta12-40 ug/mL EthionamidecellWall

-2.021

INH0.2-0.4 ug/mL IsoniazidcellWall

-2.063

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.435

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.083

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.061

BZA0.12 mg/mL BenzamidearomaticAmides

-0.305

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.425

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.509

H2O24 mM hydrogen peroxideDNAdamaging

-0.176

Levo10 ug/mL LevofloxacinDNAdamaging

-0.555

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.007

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.337

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.243

UVUV-irradiationDNAdamaging

-0.466

ARP41-4 ug/mL Antitubercular compound ARP4?

0.256

Antimycin12.5-50 ug/mL Antimycin A?

-0.428

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.324

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.308

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.545

PA8240.2-2 ug/mL PA-824?

0.357

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.542

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.344

Verapamil50 uM Verapamil?

-0.808

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.312

methoxatin10-20 ug/mL Methoxatin?